Current Good Manufacturing Practices (CGMP)
Our expert team has extensive knowledge of the Code of Federal Regulations 21 CFR Parts 210, 211, 212, 1271 and others, as well as HCT/P compliance and Quality Systems regulations in the US and EU. Our biologics experts have a complete understanding of GMP and GTP regulatory requirements and work closely with scientific staff to understand their processes and help transfer them into the GMP manufacturing phase and then into the clinical setting.
Drug Delivery
We help medical device and pharmaceutical companies bring innovative new drug and biologic delivery systems to market safely and effectively. We provide risk assessment, program development, engineering support, facility operations and operational Q&A support. From initial concept to regulatory approval, we bring together world-class expertise to help our clients solve their biggest developmental and operational challenges.
USP <797>, <800>, and 503 A & B
We offer a wide variety of services to pharmacies to assist in compliance with
USP <797>, <800>, <823/825> and with FDA 503 A & B pharmacy programs. We review pharmacy engineering and administrative controls; operations; behaviors and practices of compounding personnel; environmental conditions and monitoring; labeling and storage procedures; and a number of other areas critical for the proper compounding of sterile preparations and ensuring patient and personnel safety. We create an action plan comparing current practices against the requirements of USP <797> and <800> and items that need to be addressed to achieve compliance. We also assist our clients in all phases of establishing and maintaining 503 A & B programs.
Pharmacy Compounding Standard Operating Procedures
Accurate and updated policies and a well-trained staff are crucial to ensuring the safety of patient care and medication compounding.
Our team of compounding experts will work with you to review your existing cleanroom workflows and develop a complete set of Pharmacy Compounding Standard Operating Procedures to ensure compliance with USP <797>, <800>, and <823> (if applicable), FDA Sections 503A and B, and State Boards of Pharmacy. Staff training sessions are also available to ensure pharmacy, maintenance, and environmental services staff are compliant with the revised SOPs. Topics addressed include: Compounding facilities and engineering controls, HVAC and HEPA filters, environmental monitoring and control systems, cleaning and disinfecting, environmental monitoring, aseptic technique, garbing and hand hygiene, and others.
CGMP for Cord Blood
Our services for cord blood banking go beyond the physical facility. We ensure the design of the facility complies with the FDA regulations regarding the movement of people, equipment, and supplies into and out of the space. During construction, whether for modifications or a new build, we provide construction quality control (CQC). We also check for appropriate redundancies in critical systems and verify environmental monitoring for temperature, relative humidity, differential air pressure, and documentation compliance.
Hazardous Drug (HD) Exposure and Risk Management
With the publication and enforcement of USP <800>, it is critical that healthcare systems are equipped to ensure ongoing and sustainable compliance for managing hazardous drugs (HD). USP <800> applies to all healthcare personnel who handle hazardous drug preparations and any entity that stores, prepares, transports, or administers HDs. Pharmacy and nursing personnel are the most common staff that are exposed to hazardous drugs and many healthcare facilities have already taken extensive steps to protect these clinical staff members during preparation and administration activities. Our integrated team of USP compliance experts, WorkingBuildings and SafeBridge, provides comprehensive USP <800> services.